Arkolith/Insider Trading/ENSC/Form 4

Gower Bob G

DirectorEnsysce Biosciences, Inc. (ENSC) · full profile →Form 4 · filed Feb 1, 2023
Net Buying
Open-Market Buys
$500K
Open-Market Sells
$0
Net Open-Market Flow
$500K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 9, 2022Buy(P)357K$1.40$500K753K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 9, 2022Grant(A)714K——716K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-23-003343) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Ensysce Biosciences, Inc.

Build

Ask your agent about ENSC insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001493152-23-003343"
Ask your agent
Use Arkolith to summarize insider buying and selling at Ensysce Biosciences, Inc.
over the last 90 days and cite the filings.